ArticleAIDS care2026
Facilitators and barriers to anal cancer screening among men with HIV and their providers in Alabama.
Article in AIDS care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Anal cancer, primarily caused by persistent high-risk HPV infection, is increasing worldwide. Men who have sex with men (MSM) and men with HIV (MWH) have incidence rates over ten-fold the rate among the general population. We explored health beliefs related to anal cancer, and perceived benefits, barriers, and facilitators to screening among MWH and their HIV care providers in the U.S. South, where HIV incidence remains high. We conducted in-depth interviews and thematic analyses to identify themes related to health beliefs (i.e., perceived knowledge of HPV and cancer, benefits of screening, and self-efficacy), barriers and facilitators to screening. Among MWH (N=12), benefits of screening included early detection to prevent negative outcomes and awareness about one's body. Among providers (N=4), suggestions for overcoming barriers to screening included access to standard screening guidelines, patient education, inclusion of screening into routine care, social work services, and self-collection. Among MWH that were aware of HPV-associated cancers, perceived risk of cancer and a desire to receive HPV vaccination were common. In conclusion, improving patient education about HPV-associated cancer, inclusion of screening as part of routine care, and access to self-collection kits could facilitate anal cancer screening uptake among MWH in the South.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.